Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan. The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123

Reference

Title
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan
Volume & Issue
Volume 26, Issue 1
Pages
111-123

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.  
  • A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to…  
  • Over the past 15 years, three classes of drugs have reduced mortality and improved symptoms of heart failure in patients who have decreased heart muscle function. These classes of drugs…  
  • Death Rates for Coronary Heart Disease, 1950-1998  
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…